Metastatic prostate cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate Cancer
Abstract Background The European Randomized Study of Screening for Prostate Cancer
(ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold …
(ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold …
[PDF][PDF] Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate …
C Buzzonia, A Auvinen, MJ Roobol, S Carlsson… - academia.edu
Abstract Background: The European Randomized Study of Screening for Prostate Cancer
(ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold …
(ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold …
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.
C Buzzoni, A Auvinen, MJ Roobol, S Carlsson… - European …, 2015 - folia.unifr.ch
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from
the European Randomized Study of Screening for Prostate Cancer. SONAR logo Log in Sign up …
the European Randomized Study of Screening for Prostate Cancer. SONAR logo Log in Sign up …
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer
C Buzzoni, A Auvinen, MJ Roobol, S Carlsson… - 2015 - pubmed.ncbi.nlm.nih.gov
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC)
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.
C Buzzoni, A Auvinen, MJ Roobol, S Carlsson… - European …, 2015 - europepmc.org
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC)
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
[HTML][HTML] Metastatic Prostate Cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate …
C Buzzoni, A Auvinen, MJ Roobol, S Carlsson… - European …, 2015 - ncbi.nlm.nih.gov
Background The European Randomized study of Screening for Prostate Cancer (ERSPC)
has shown a 21% reduction in prostate cancer (PC) mortality and a 1· 6-fold increase in PC …
has shown a 21% reduction in prostate cancer (PC) mortality and a 1· 6-fold increase in PC …
Metastatic prostate cancer incidence and prostate-specific antigen testing: New insights from the European Randomized Study of Screening for Prostate Cancer
C Buzzoni, A Auvinen, MJ Roobol… - European …, 2015 - researchportal.tuni.fi
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC)
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer
C Buzzoni, A Auvinen, MJ Roobol, S Carlsson… - European Urology, 2015 - infona.pl
The European Randomized Study of Screening for Prostate Cancer (ERSPC) has shown a
21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in PCa incidence …
21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in PCa incidence …
Metastatic prostate cancer incidence and prostate-specific antigen testing: New insights from the European Randomized Study of Screening for Prostate Cancer
C Buzzoni, A Auvinen, M Roobol-Bouts… - … : Official Journal of the …, 2015 - repub.eur.nl
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC)
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in …
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer
C Buzzoni, A Auvinen, MJ Roobol, S Carlsson… - European …, 2016 - hal.univ-reunion.fr
Background-The European Randomized study of Screening for Prostate Cancer (ERSPC)
has shown a 21% reduction in prostate cancer (PC) mortality and a 1• 6-fold increase in PC …
has shown a 21% reduction in prostate cancer (PC) mortality and a 1• 6-fold increase in PC …